PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Angelini Pharma Launches New Crowdsourcing Challenge to Fund Innovative Solutions to Drug Adherence and Management of Epilepsy

Angelini Pharma [1], part of the privately owned Angelini Industries, has launched a new crowdsourcing campaign to identify innovative new Drug Delivery Systems (DDS...
Continue Reading →
News

Meet Gaelic Laboratories, your trusted testing and manufacturing partner

Gaelic Laboratories unveils its new website today, launching an upgraded and expanded laboratory technology base for advanced analytical testing, and a newly re-...
Continue Reading →
News

CPHI Returns to the Messe Frankfurt in 2025

The Heart of Pharma will return to Europe’s leading pharma manufacturing region The world's largest pharmaceutical event, CPHI Europe, will return to Messe F...
Continue Reading →
News

Mim8 demonstrated superior reductions in annualised bleeding rate (ABR) compared to on-demand and prior prophylaxis treatment in people with haemophilia A

FRONTIER2 data presented at ISTH 2024 showed that up to 95% of people, who had no prior prophylaxis treatment, experienced zero treated bleeds while on Mim8. Bags...
Continue Reading →
News

First Conference ”Advancements in Animal-Free Research and Translational Medicine” in Munich

[Munich, Planegg, 16.05.2024] – PELOBIOTECH GmbH is happy to announceorganizing the first conference "Advancements in Animal-Free Research andTranslational Medicine"...
Continue Reading →
News

Researchers identify genetic changes responsible for rare childhood immune disorders

Affecting the immune system, various forms of SCID are estimated to affect one in 75,000 to 100,000 newborns. A new study led by Newcastle University has identifi...
Continue Reading →
News

BHF awards £35m funding to nine UK universities for cardiovascular disease

Affecting more than 7 million people in the UK, cardiovascular diseases are conditions that affect the heart or circulation. The British Heart Foundation (BHF) ha...
Continue Reading →
News

LifeArc and ALS TDI announce partnership to develop new clinical tools for ALS and MND

The project will validate two minimally invasive biomarkers for ALS: MMP-9 and TIMP-1. LifeArc and the ALS Therapy Development Institute (ALS TDI) have partnered ...
Continue Reading →
News

MRC awards two medical research units at University of Cambridge £30m in funding

The MRC BRC and the MDU will use the funding and cutting-edge research to improve public health until March 2029. The Medical Research Council (MRC) has awarded t...
Continue Reading →
News

King’s Doctoral Training Centre to investigate MS symptom management

Impacting more than 150,000 people in the UK, the lifelong autoimmune disease affects the brain and spinal cord. A new King’s Doctoral Training Centre at the Inst...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026